http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9624333-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_087bed7abab91ae0f927879f9fe8b273 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-88 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate | 1996-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57503bd3314a3fcfd297ad42d091cd0c |
| publicationDate | 1996-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9624333-A1 |
| titleOfInvention | Lipid constructs for targeting to vascular smooth muscle tissue |
| abstract | A lipid construct comprising an aminmannose derivatized cholesterol suitable for targeting smooth muscle cells and tissue. Preferred formulations contain 6-(cholest-5-en-3β-yloxyl)hexyl-6-amino-6-deoxy-1-thio-α-D-mannopyranoside in liposome formulations wherein the formulations are delivered generally to arteries using percutaneous transluminal coronary angioplasty procedures. These formulations have applications in the reduction of restenosis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0119400-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0119400-A3 |
| priorityDate | 1995-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 385.